Enovis to Participate in Upcoming Investor Conferences
18. November 2024 16:10 ET
|
Enovis Corporation
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Third Quarter 2024 Results
06. November 2024 06:00 ET
|
Enovis Corporation
Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9%...
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
10. Oktober 2024 07:00 ET
|
Enovis Corporation
Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
09. September 2024 15:50 ET
|
Enovis Corporation
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the...
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
05. September 2024 08:00 ET
|
Enovis Corporation
Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology company, announced today it will unveil its new Tarsoplasty Percutaneous Lapidus...
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
20. August 2024 08:00 ET
|
Enovis Corporation
WILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, announced today the expansion of its EMPOWR Revision Knee™ system to...
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
19. August 2024 08:00 ET
|
Enovis Corporation
Wilmington, DE, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, proudly unveils its Scandinavian Total Ankle Replacement (STAR®...
Enovis to Participate in Upcoming Investor Conferences
12. August 2024 16:10 ET
|
Enovis Corporation
Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Second Quarter 2024 Results
07. August 2024 06:00 ET
|
Enovis Corporation
Continued strong momentum with second-quarter sales growth of 23% on a reported basis and strong adjusted margin expansionReported second-quarter net loss from continuing operations of $0.34 per share...
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
25. Juli 2024 06:00 ET
|
Enovis Corporation
Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced a change in the scheduling of its upcoming...